Business

Pfizer Boosts Dividend More Than Expected

By Chad Brand of Peridot CapitalistLate Monday drug giant Pfizer (PFE) announced a 21 percent increase in its annual dividend, to $1.16 per share. With the stock trading at $25 ...
Read Full Story »

Tuesday’s Top Biotech and Medical Stocks

From BioHealth InvestorBiotechnologyHESKA CORPORATION [HSKA] +10.67% IDERA PHARMACEUTICAL [IDP] +8.76% NUTRITION 21 INC [NXXI] +8.00% METABASIS THERAPEUTI [MBRX] +5.19% CYTORI THERAPEUTICS [CYTX] +4.76% Diagnostic SubstancesIMMUNOMEDICS INC [IMMU] +11.11% SYNOVICS PHARMACEUTL ...
Read Full Story »

Cramer’s Christmas Stock(ing) Stuffer

Cramer has another Christmas play on MAD MONEY tonight.  He called it the 12 days of Cramer, which is really 4 plays that work in Christmas without you knowing it ...
Read Full Story »

Cramer Calls for InnerWorkings

Cramer says you can learn from the dot.com bubble blow-ups and know how to avoid repeats in many hot stocks of today.  A stock he likes is InnerWorkings (INWK).  It's ...
Read Full Story »

Cramer Says Bahumbug to the Ford Upgrade

On today's STOP TRADING segment, Cramer was baffled on research being bogus.The recommendation on Ford (F) from Morgan Stanley on the Overweight rating is flawed.  He said this could be ...
Read Full Story »
Chart

Media Stock Six Month Moves

Intraday  1 Mo  2 Mo  3 Mo  6 Mo  9 Mo  YTD  1 Yr  2 Yr  3 Yr  5 Yr  10 Yr  Chart from AOL Finance ...
Read Full Story »

If Chinese Car Companies Can Do Europe, Why Not The US? (F)

Ford's Chinese auto joint venture partner in China, Jiangling Motors Co. Group, is planning to raise its presence in Europe next year to 500 car dealers. The company obviously believes ...
Read Full Story »

Honda Swings For The Fences (HMC)(TM)

It is not enough that Toyota expects a banner 2007, now Honda has jumped on the band wagon.The Japanese car company expects unit sales to rise 5% worldwide to 3.55 ...
Read Full Story »

Media Digest 12/19/2006 Reuters, NYTimes, Barron’s, WSJ, FT

Stocks:  (GSK)(EBAY)(TOMO)(HMC)(T)(BLS)(WMT)(YHOO)According to Reuters, GlaxoSmithKline Plc has bought global rights to Danish biotech company Genmab's most promising new drug, a treatment for leukemia, in a record deal worth up to ...
Read Full Story »

Monday’s Top Biotech and Medical Stocks

From BioHealth InvestorBiotechnologyBIOSANTE PHARMA INC [BPA] +24.60% REPROS THERAPEUTICS [RPRX] +11.83% SUNESIS PHARMACEUTIC [SNSS] +11.72% POINT THERAPEUTICS [POTP] +8.91% IMMTECH PHARM INC [IMM] +8.38% Diagnostic SubstancesSYNOVA HEALTHCARE GR [SNVH.OB] +21.82% ...
Read Full Story »

Biogen Idec & Genentech Down on Rituxan Related Deaths

From BioHealth Investorby H.S. AyoubBioHealthInvestor.comShares of Biogen Idec Inc. (BIIB) and Genentech, Inc. (DNA) are down in after hours trading on Monday after issuing a letter to physicians and other ...
Read Full Story »

CNBC: Stop Hyping Your New Web Site!

By Chad Brand of Peridot CapitalistA few years back CNBC, in partnership with MSN and some investment companies, began promoting the "StockScouter" ranking system. The quantitative formula ranked stocks using ...
Read Full Story »

Cramer Pumps Up GMarket..as the next eBay

Cramer said you need to look at Internet companies not for value but you want them for growth.  Cramer was discussing the next eBay (EBAY) as a stock called G-Market ...
Read Full Story »

Cramer Discusses Omniture (OMTR)

Cramer said you can look for growth, but make sure youget the right growth.  Everyoneone wants a hot stock, but very few determine what they really do.  He will do ...
Read Full Story »

Biogen-Idec & Genentech Trading Down on Rituxan Death Reports

by Jon C. OggDecember 18, 2006Biogen Idec Inc. (BIIB) and Genentech, Inc. (DNA) are issuing a DEAR HEALTHCARE PROVIDER letter to physicians and other prescribers, including rheumatologists, neurologists, oncologists, hematologists, ...
Read Full Story »